A REVIEW OF SEMAGLUTIDE WEEK 1-12 BUNDLE

Thyroid C-mobile Tumors: In rodent studies, semaglutide continues to be shown to lead to thyroid C-cell tumors. It's unknown irrespective of whether this chance applies to people, but semaglutide is contraindicated in patients with a personal or relatives background of medullary thyroid carcinoma (MTC) or patients with Numerous Endocrine Neoplasia